Research output
Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study
Research output: Contribution to journal › Article › Academic › peer-review
Associated researcher
Associated organisations
- Non-small cell lung cancer, Individualized radiotherapy, Concurrent chemotherapy radiotherapy, Phase II trial, Prospective, NORMAL TISSUE CONSTRAINTS, LOCALLY ADVANCED HEAD, LONG-TERM SURVIVAL, RADIATION-THERAPY, PHASE-III, DOSE-ESCALATION, RADIOTHERAPY, CHEMOTHERAPY, TRIAL, CISPLATIN